GlassScriptPhysician profile
Maurice D Richardson
NPI 1700078342
$337.81
in general payments reported to CMS, 2019-2025
9 companies · $63.85 in 2025
The $63.85 reported for 2025 was more than what a typical Anatomic Pathology & Clinical Pathology provider received nationally (typical 2025 total: $50.59).
See the full distribution for Anatomic Pathology & Clinical Pathology
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2020: $144 · 2021: $50.85 · 2022: $12.63 · 2023: $44.81 · 2024: $21.83 · 2025: $63.85.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $130.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $130.49 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Amgen INC. | $125.00 | 2020 | |
| Merck Sharp & Dohme LLC | $68.99 | 2022-2025 | Lynparza, Keytruda |
| Roche Diagnostics Corporation | $26.49 | 2025 | |
| Lilly USA, LLC | $25.66 | 2023 | |
| Adaptive Biotechnologies Corporation | $21.98 | 2025 | Clonoseq |
| Werfen USA LLC | $21.39 | 2021 | |
| Glaxosmithkline, LLC. | $18.84 | 2020 | |
| Sysmex America, INC. | $16.24 | 2021 | |
| Alexion Pharmaceuticals, INC. | $13.22 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Maurice Richardson listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.